Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Wednesday, July 23, 2014 7:26:25 AM
HHSE Financial Audits
6/6/14
3). CORPORATE MATTERS - We're very pleased to announce the completion of the Form 10 Registration Statement; this document will be filed with the S.E.C. Edgar Database upon approval of Hogan-Taylor regarding their sign-off on the 2012 and 2013 audits. HHSE is pushing for a filing within the short-term future. All of the absurd theories from skeptics about the audit filing delays will be put to a rest, and management's prior filings and amendments will be shown to be substantially consistent with the sign-off.
http://hannoverhousemovies.blogspot.com/2014/06/friday-updates-hannover-house.html
2/23/14
The Audits are still progressing with Hogan-Taylor LLP. The completed audit report binder, containing over 600 pages of financial data and supporting documentation, was made available for shareholders meeting attendee review; however, the audit opinion letter from Hogan-Taylor is not yet ready for release pending revision of the items / issues described at the meeting and below.
Back-Up Reports Still Required - on the Company's balance sheets, under assets, are three items for which the back-up support is extraordinarily complex and data intensive. These items are:
1.) Prepaid Producer Royalties
2.) Producer Marketing Recoupment
3.) Film Distribution Rights
When the Company announced the Shareholder's Meeting, it was believed that the reallocation of payments could be completed faster than has proven to be the case. With over 20,000 invoices to review against payments, the company's new bookkeeper took 8-weeks just to complete the payments from 2012 - and he is now working on payments for 2013 and will move next to 2011 (so that the Company will have a full 3-years of Audits).
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=99612087
HHSE
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM